Review
Accepted on 07 Apr 2025
Towards the Elimination of Infectious HPV: Exploiting CRISPR/Cas Innovations
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528568
Type at least 3 characters
365 articles
Systematic Review
Published on 07 Apr 2025
Global trends in antimicrobial resistance of Enterococcus faecium: a systematic review and meta-analysis of clinical isolates
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1505674
Original Research
Published on 04 Apr 2025
Antiviral activity of eicosapentaenoic acid against zika virus and other enveloped viruses
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564504
- 318 views
Original Research
Published on 04 Apr 2025
Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516013
- 146 views
Original Research
Published on 04 Apr 2025
Composite outcome of oral azvudine vs. nirmatrelvir-ritonavir in COVID-19 patients: a retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1546787
- 112 views
Original Research
Published on 03 Apr 2025
Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545108
- 129 views
Review
Accepted on 01 Apr 2025
Advances in the Effectiveness and Safety of Azvudine Treatment: A Comprehensive Review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1524072
Review
Published on 01 Apr 2025
Natural compounds: new therapeutic approach for inhibition of Streptococcus mutans and dental caries
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1548117
- 295 views
Original Research
Published on 01 Apr 2025
Icarisid â…ˇ modulates mitochondrial dynamics for anti-HBV activity
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544714
- 185 views
Systematic Review
Accepted on 31 Mar 2025
Global Trends in Extended-Spectrum Cephalosporin Resistance in Neisseria gonorrhoeae: A Systematic Review and Meta-Analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527128
Brief Research Report
Accepted on 31 Mar 2025
Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537018
Editorial
Published on 31 Mar 2025
Editorial: Emerging and reemerging neglected tropical diseases: epidemiology, transmission, mitigation, and vaccines and chemotherapy advancements
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545801
- 299 views
Original Research
Published on 31 Mar 2025
Appraisal of guidelines and variations in recommendations on drug therapy for invasive aspergillosis prevention and treatment
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1443487
- 169 views
Original Research
Published on 31 Mar 2025
The efficacy and safety of ceftazidime/avibactam or polymyxin B based regimens for carbapenem-resistant Pseudomonas aeruginosa infection: a multicenter real-world and propensity score-matched study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533952
- 209 views
Original Research
Published on 28 Mar 2025
Optimizing fluconazole dosing in acute renal failure patients undergoing continuous renal replacement therapy: A population pharmacokinetic/pharmacodynamic study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564070
- 240 views
Original Research
Published on 27 Mar 2025
High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1555276
- 237 views